“…The macrocyclic ligands 3,6,9,16,19,22-hexaazatricyclo[22.2.2.2 11,14 ]-triaconta-1(27),11 (30),12,14(29),24(28),25-hexaene (H2p), 3,7,11,18, 22,26-hexaazatricyclo[26.2.2.2 13,16 ]tetratriaconta-1(31),13(34), 14,16(33),28(32),29-hexaene (H3p), 3,6,9,16,19,22-hexamethyl-3,6,9,16,19,22-hexaazatricyclo[22.2.2.2 11,14 ]triaconta-1(27),11 (30), 12,14(29),24(28), 6,9,17,20,6,9,17,20,15 ]triaconta-1(29), 11,13,15(30),25,3,7,11,18,22,7,11,18,22,16 ]tetratriaconta-1(31), 13(34),14,16(33), 28(32), 7,11,19,23,7,11,19,23,17 ]tetratriaconta-1(33), 13,15,17(34),29, were prepared according to the published procedures or slight modifications thereof.…”